Pharmacist Issues Warning Over Wernicke’s Encephalopathy Risks Tied to Weight-Loss Jabs
A rare brain disorder linked to vitamin B1 deficiency has been identified in a small number of patients using popular weight-loss medications like Mounjaro, Wegovy, and Ozempic, according to health warnings issued across multiple outlets. The condition, known as Wernicke’s encephalopathy, affects the nervous system and can trigger confusion, balance issues, and unusual eye movements if left untreated.
TikTok Pharmacist Highlights 15 Reported Cases Among GLP-1 Users
Raj Patel, a UK-based pharmacist with more than 100,000 followers on TikTok, addressed the neurological condition in a recent video discussing prescription drugs containing semaglutide or tirzepatide, as reported by thesun.ie. Patel told his audience that researchers had identified 15 clinical reports of the rare brain condition among individuals using these specific GLP-1 receptor agonists. According to data cited by the Irish Mirror and Dublin Live, an estimated 1.6 million adults across the UK and Ireland use medications like Wegovy and Mounjaro to support weight loss.
Further details from the research show that 13 of the 15 patients experienced significant gastrointestinal or nutritional complications, including severe vomiting, rapid weight loss, loss of appetite, or malnutrition. Medical experts emphasize that while these findings highlight a rare risk, they do not definitively prove that the injections directly caused every case of the condition.
Recognizing Symptoms and Avoiding Dismissal of Persistent Side Effects
Wernicke’s encephalopathy stems from a critical shortage of thiamine, an essential nutrient that helps the brain utilize energy from food and supports normal nervous system function. The condition is characterized by three primary warning signs: new confusion, difficulty walking or poor balance, and abnormal eye movements. Patients do not need to exhibit all three symptoms for a diagnosis to be considered.
Pharmacist Raj Patel urged patients experiencing persistent vomiting not to assume it is merely a normal side effect of their medication. In statements reported by the Irish Mirror, he advised individuals to contact their prescriber immediately if they are struggling to keep fluids down or manage proper nutrition. The Health Service Executive (HSE) similarly advises patients to consult healthcare professionals before starting obesity medications, noting that side effects can range from common digestive issues to low blood pressure and fatigue.
Frequently Asked Questions
What is Wernicke’s encephalopathy?
Wernicke’s encephalopathy is a serious neurological condition caused by a severe deficiency of vitamin B1, also known as thiamine. It affects brain function and can lead to lasting complications if treatment is delayed.
Which medications are associated with these findings?
A study published in Clinical Nutrition associated 15 reports of the condition with GLP-1 receptor agonists, specifically medications containing semaglutide (such as Wegovy and Ozempic) and tirzepatide (such as Mounjaro).
When should a patient seek immediate medical attention?
Patients experiencing persistent vomiting, inability to keep fluids down, severe abdominal pain, or neurological warning signs such as confusion, balance issues, and abnormal eye movements should contact their GP, prescriber, or NHS 111 promptly.
Keep reading